ESR1 and breast carcinoma: This discrepancy may, however, be due to the difference in origin of the cell lines since our E2 results are in agreement with published data in ERβ overexpressed, human ovarian, and breast cancer cell lines that express endogenous ERα; ERβ has a dominant, negative influence on ERα activity12,13,29, 30.